Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer

por Zhang, Guian, Luo, Yong, Dong, Weimin, Zhong, Weide
Publicado 2022

Analysis of the Role of Comprehensive Treatment Model in the Treatment of Prostate Cancer

por Yang, Shuai, Guan, Han, Chen, Zhijun, Wang, Sheng, Wu, Hongliang, Zhong, Weide
Publicado 2022

Identification and validation of a signature involving voltage-gated chloride ion channel genes for prediction of prostate cancer recurrence

por Luo, Yong, Liu, Xiaopeng, Li, Xiaoxiao, Zhong, Weide, Lin, Jingbo, Chen, Qingbiao
Publicado 2022

Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer

por Ye, Yongkang, Mo, Rujun, Zheng, Ruinian, Zou, Jun, Liu, Shaoqian, Mi, Qiwu, Zhong, Weide
Publicado 2023

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation

por Kuang, Qiwen, Liang, Yuxiang, Zhuo, Yangjia, Cai, Zhiduan, Jiang, Funeng, Xie, Jianjiang, Zheng, Yu, Zhong, Weide
Publicado 2021

Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer

por Dong, Weimin, Luo, Yong, Zhang, Guian, Zhang, Hui, Liang, Yuxiang, Zhuo, Yangjia, Liang, Yingke, Zou, Fen, Zhong, Weide
Publicado 2020

MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N‐cadherin pathway

por Xie, Qingling, Liu, Ren, Zou, Zhihao, Feng, Yuanfa, Huang, Yiqiao, Xu, Guibin, Sun, Wei, Liang, Yuxiang, Zhong, Weide
Publicado 2022

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in...

por Lu, Jianming, Chen, Jiahong, Lin, Zhuoyuan, Liu, Qinwei, Zhong, Chuanfan, Cai, Zhouda, Jia, Zhenyu, Zhong, Weide, Liang, Yingke, Cai, Chao
Publicado 2023

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer

por Zeng, Jie, Chen, Jiahong, Li, Maozhang, Zhong, Chuanfan, Liu, Zezhen, Wang, Yan, Li, Yuejiao, Jiang, Funeng, Fang, Shumin, Zhong, Weide
Publicado 2023

Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Anal...

por Wang, Wei, Wan, Minghui, Liao, Dongjiang, Peng, Guilin, Xu, Xin, Yin, Weiqiang, Guo, Guixin, Jiang, Funeng, Zhong, Weide, He, Jianxing
Publicado 2017

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment

por Zhou, Rui, Feng, Yuanfa, Ye, Jianheng, Han, Zhaodong, Liang, Yuxiang, Chen, Qingbiao, Xu, Xiaoming, Huang, Yuhan, Jia, Zhenyu, Zhong, Weide
Publicado 2021

EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway

por Wang, Yan, Luo, Shiyong, Wang, Yuxuan, Yang, Shengbang, Huang, Zhitong, Zhu, Xuejin, Cai, Shanghua, Guo, Qifeng, Zhong, Weide, Liu, Sihong
Publicado 2022

Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells

por Ge, Rongbin, Wang, Zongwei, Wu, Shulin, Zhuo, Yangjia, Otsetov, Aleksandar G., Cai, Chao, Zhong, Weide, Wu, Chin-Lee, Olumi, Aria F.
Publicado 2015

FCGR3A: A new biomarker with potential prognostic value for prostate cancer

por Zha, Zeyu, Hong, Yuan, Tang, ZhenFeng, Du, Qiuling, Wang, Yan, Yang, Shengbang, Wu, Yongding, Tan, Huijing, Jiang, Funneng, Zhong, Weide
Publicado 2022

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer

por Zhang, Yanqiong, Jiang, Funeng, He, Huichan, Ye, Jianheng, Mao, Xia, Guo, Qiuyan, Wu, Shu-lin, Zhong, Weide, Wu, Chin-Lee, Lin, Na
Publicado 2018

Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer

por Chen, Jiahong, Huang, Yaqiang, Tang, Zhenfeng, Li, Maozhang, Ling, Xiaohui, Liao, Jinxian, Zhou, Xiaobo, Fang, Shumin, Zhao, Haibo, Zhong, Weide, Yuan, Xia
Publicado 2021

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer

por Feng, Yuanfa, Deng, Yulin, Tang, Zhenfeng, Cai, Shanghua, Li, Jinchuang, Liu, Ren, Wan, Jiaming, He, Huichan, Zeng, Guohua, Ye, Jianheng, Han, Zhaodong, Zhong, Weide
Publicado 2023

miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression

por Cai, Chao, He, Huichan, Duan, Xiaolu, Wu, Wenqi, Mai, Zanlin, Zhang, Tao, Fan, Junhong, Deng, Tuo, Zhong, Wen, Liu, Yongda, Zhong, Weide, Zeng, Guohua
Publicado 2018

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement

por Dong, Weimin, Zheng, Jiefang, Huang, Yiqiao, Tan, Huijing, Yang, Shengbang, Zhang, Zhiming, Liang, Xue, Liu, Hao, Zeng, Guohao, Xu, Haoming, Jiang, Xianhan, Zhong, Weide
Publicado 2022

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression

por Cai, Chao, He, Huichan, Duan, Xiaolu, Wu, Wenqi, Mai, Zanlin, Zhang, Tao, Fan, Junhong, Deng, Tuo, Zhong, Wen, Liu, Yongda, Zhong, Weide, Zeng, Guohua
Publicado 2023